Third, co-morbidities common in patients with atherosclerotic CVD, e.g. hypertension and type 2 diabetes mellitus, increase sCD40L levels, which may hamper the prognostic potential of sCD40L in acute CVD [62, 65]. This evidence concerns the gene CD40LG and diabetes mellitus.